UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000961
Receipt number R000001156
Scientific Title Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers
Date of disclosure of the study information 2008/01/07
Last modified on 2012/01/06 12:07:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers

Acronym

Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers

Scientific Title

Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers

Scientific Title:Acronym

Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers

Region

Japan


Condition

Condition

colorectal cancers

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety of liver resection for metastatic lesions from colorectal cancers after neoadjuvant chemotherapy (mFOLFOX6)

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Curative resection rates of liver metastases

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Surgery

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histologically diagnosed as colorectal adenocarcinomas, including cecal, appendecal, and anal canal cancers.
2) Liver lesions are measurable by spiral CT or SPIO-MRI scans.
3) Extrahepatic lesions include lung metastases which can be resected curatively.
4) Curative resection for metastatic lesions can be performed with residual hepatic functions preserved.
5) No prior treatment histories for liver lesions, including L-OHP regimens, hepatectomy, hepatic arterial infusion, MCT, or RFA
6) No evidence of chronic hepatic diseases which affect systemic chemotherapy and/or surgical resection
7) Performance status (ECOG): 0-1
8) Vital organ functions, including hematopoietic, cardiac, respiratory and renal functions, are preserved.

Key exclusion criteria

Excluded are cases with conditions as below:
1) Peritoneal or pleural fluid retention to be drainaged.
2) Multiple malignancies to be treated.
3) Peripheral neural disturbances.
4) Active infectious diseases.
5) Severe watery diarrhea.
6) Mental disturbances.
7) Treatment history of continuous, oral or intravenous steroid therapy.
8) Previous history of ischemic heart diseases.
9) Coexistent severe diseases including pulmonary fibrosis, interstitial pneumonia, ileus, uncontrollable diabetes, cardiac dysfunction, hepatic failure, or renal failure.
10) Pregnant.
11) Previous history of severe drug-induced allergy.

Target sample size

27


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Nagayama

Organization

Kyoto Univ Hospital

Division name

Surgery

Zip code


Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto City

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kyoto Univ Hospital

Division name

Surgery

Zip code


Address


TEL

075-751-3227

Homepage URL


Email



Sponsor or person

Institute

Dept. Surgey
Kyoto University Hospital

Institute

Department

Personal name



Funding Source

Organization

Dept. Surgey
Kyoto University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 01 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2007 Year 12 Month 25 Day

Date of IRB


Anticipated trial start date

2008 Year 01 Month 01 Day

Last follow-up date

2013 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 12 Month 30 Day

Last modified on

2012 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001156


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name